GlucoTrack announces USD 11.5 million convertible notes offering
GCTK•Convertible notes offering details
GlucoTrack announced definitive agreements for USD 11.5 million of convertible notes, including USD 4.5 million of new cash investment.
The transaction includes USD 4.5 million of existing notes rolled over, with aggregate principal reflecting a 22% original issue discount.
The convertible debt carries an initial conversion price of USD 3.12 per share.
Investors also receive warrants exercisable at USD 7.50 per share.
Dawson James Securities is sole placement agent.
